Innovative Medicines named in seven new filings
This week is the last one in which the House will sit in 2023, barring any last-minute scheduling changes or emergency meetings.
Source: ipolitics.ca
Interim Order Respecting News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Interim Order Respecting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Interim Order Respecting Today - Breaking & Trending Today
Cue Health's Pioneering Smart Home Lab and PCR-quality COVID-19 Test Now Available in Canada
Cue's molecular COVID-19 self-test provides lab-quality results in 20 minutesSAN DIEGO, March 16, 2022 /PRNewswire/ -- Cue Health ('Cue') (Nasdaq:...
Source: businessinsider.com
Cue Health's Pioneering Smart Home Lab and PCR-quality COVID-19 Test Now Available in Canada
Cue's molecular COVID-19 self-test provides lab-quality results in 20 minutes SAN DIEGO, March 16, 2022 /PRNewswire/ -- Cue Health , the healthcare technology company behind the most... | March 16, 2022
Source: marketscreener.com
GSK Signs Addl Purchase Agreements With Canada For COVID-19 Monoclonal Antibody Therapy, Sotrovimab
LONDON (dpa-AFX) - GlaxoSmithKline Plc. (GSK.L, GSK) said that it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab for injection. Sotrovimab is a COVID-19
Source: finanznachrichten.de
Bharat Biotech partner Ocugen seeks approval for Covaxin in Canada
Bharat Biotech partner Ocugen seeks approval for Covaxin in Canada Ocugen Inc., Bharat Biotech's partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing. The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said on Thursday. Often referred to as a rolling review, this allows Health Canada to start its review right away, as information continues to come in, to accelerate the overall review...
Source: indiatvnews.com